UNIGENE LABORATORIES INC Debt Instrument, Convertible, Beneficial Conversion Feature
UNIGENE LABORATORIES INC reported Debt Instrument, Convertible, Beneficial Conversion Feature of $10.39 million for the 12-month period ending 2011-12-31, per its 10-K/A filed 2013-01-31.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature · last filed 2013-01-31
- UNIGENE LABORATORIES INC debt instrument, convertible, beneficial conversion feature for the quarter ending 2010-12-31 was $6.46M.
- UNIGENE LABORATORIES INC debt instrument, convertible, beneficial conversion feature for the quarter ending 2010-09-30 was $0.00.
- UNIGENE LABORATORIES INC debt instrument, convertible, beneficial conversion feature for the quarter ending 2010-06-30 was $1.91M.
- UNIGENE LABORATORIES INC debt instrument, convertible, beneficial conversion feature for fiscal 2011 was $10.39M.
- UNIGENE LABORATORIES INC debt instrument, convertible, beneficial conversion feature for fiscal 2010 was -$1.67M.
| Period end | Debt Instrument, Convertible, Beneficial Conversion Feature 3 month | Debt Instrument, Convertible, Beneficial Conversion Feature 6 month | Debt Instrument, Convertible, Beneficial Conversion Feature 9 month | Debt Instrument, Convertible, Beneficial Conversion Feature 12 month | Debt Instrument, Convertible, Beneficial Conversion Feature 12 month as first filed |
|---|---|---|---|---|---|
| 2011-12-31 | $10.39M 10-K/A · filed 2013-01-31 | ||||
| 2010-12-31 | $6.46M derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-01-31 | $6.46M derived: sum of 2 quarters · filed 2013-01-31 | $8.36M derived: sum of 3 quarters · filed 2013-01-31 | -$1.67M 10-K/A · filed 2013-01-31 | -$8.13M 10-K · filed 2012-03-15 |
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | $1.91M derived: sum of 2 quarters · filed 2011-11-09 | -$8.13M 10-Q · filed 2011-11-09 | ||
| 2010-06-30 | $1.91M 10-Q · filed 2011-08-09 | -$8.13M 10-Q · filed 2011-08-09 |